These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10971112)

  • 1. Peptide-mediated immune responses in specific immunotherapy.
    Haselden BM; Kay AB; Larché M
    Int Arch Allergy Immunol; 2000 Aug; 122(4):229-37. PubMed ID: 10971112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficiency of peptide immunotherapy for respiratory allergy.
    Incorvaia C; Montagni M; Ridolo E
    Expert Rev Clin Pharmacol; 2016 Jun; 9(6):831-7. PubMed ID: 26901667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-based immunotherapy: a novel strategy for allergic disease.
    Ali FR; Larché M
    Expert Rev Vaccines; 2005 Dec; 4(6):881-9. PubMed ID: 16372883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen immunotherapy with cat allergen peptides.
    Kay AB; Larché M
    Springer Semin Immunopathol; 2004 Feb; 25(3-4):391-9. PubMed ID: 15007637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy with peptides.
    Moldaver D; Larché M
    Allergy; 2011 Jun; 66(6):784-91. PubMed ID: 21507007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell epitope-based allergy vaccines.
    Larché M
    Curr Top Microbiol Immunol; 2011; 352():107-19. PubMed ID: 21567311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulatory T cell epitope peptides: the new frontier in allergy therapy.
    Prickett SR; Rolland JM; O'Hehir RE
    Clin Exp Allergy; 2015 Jun; 45(6):1015-26. PubMed ID: 25900315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of specific immune responses by chemical and structural modifications of allergens.
    Akdis CA; Blaser K
    Int Arch Allergy Immunol; 2000 Apr; 121(4):261-9. PubMed ID: 10828716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-T-cell strategies in the treatment of allergic disease.
    Larché M
    Allergy; 2002; 57 Suppl 72():20-3. PubMed ID: 12144549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.
    Müller U; Akdis CA; Fricker M; Akdis M; Blesken T; Bettens F; Blaser K
    J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):747-54. PubMed ID: 9648701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell epitope immunotherapy ameliorates allergic responses in a murine model of shrimp allergy.
    Wai CY; Leung NY; Leung PS; Chu KH
    Clin Exp Allergy; 2016 Mar; 46(3):491-503. PubMed ID: 26610061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell targeted strategies for improved efficacy and safety of specific immunotherapy for allergic disease.
    Rolland JM; Prickett S; Gardner LM; O'Hehir RE
    Antiinflamm Antiallergy Agents Med Chem; 2013; 12(3):201-22. PubMed ID: 23597085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bee Venom Immunotherapy: Current Status and Future Directions.
    Zahirović A; Luzar J; Molek P; Kruljec N; Lunder M
    Clin Rev Allergy Immunol; 2020 Jun; 58(3):326-341. PubMed ID: 31240545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen immunotherapy: an updated review of safety.
    James C; Bernstein DI
    Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):55-59. PubMed ID: 27906697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide immunotherapy for allergic diseases.
    Larché M
    Allergy; 2007 Mar; 62(3):325-31. PubMed ID: 17298351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication with antihistamines impairs allergen-specific immunotherapy in mice.
    Johansen P; Senti G; Maria Martínez Gómez J; Kündig TM
    Clin Exp Allergy; 2008 Mar; 38(3):512-9. PubMed ID: 18081882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of immunotherapy to wasp and bee venom.
    Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
    Clin Exp Allergy; 2011 Sep; 41(9):1226-34. PubMed ID: 21729181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Treatments for Allergy: Advances in Peptide Immunotherapy.
    Calzada D; Baos S; Cremades L; Cardaba B
    Curr Med Chem; 2018; 25(19):2215-2232. PubMed ID: 29205109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.